Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
Purinergic trophic signalling in glial cells: functional effects and modulation of cell proliferation, differentiation, and death.
Coping Strategies in Multiple Sclerosis Patients with Frontal Cognitive Disorders.
A review of the sheep-multiple sclerosis connection.
Ibuprofen-induced unilateral optic neuritis.
Different mechanisms underlying changes in excitability of peripheral nerve sensory and motor axons in multiple sclerosis.
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
The Alice in Wonderland syndrome: an unusual in acute disseminated encephalomyelitis.
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Heat shock protein 27 in multiple sclerosis relapses.
Vitamin D status and ill health: a systematic review.
Transcranial direct current stimulation (tDCS) for fatigue in multiple sclerosis.
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Acid-sensing ion channels: trafficking and synaptic function.
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
Torque teno mini virus infection and multiple sclerosis.
Acute reversible periependymal ventricular enhancement in neuromyelitis optica.
[Autophagy and its role in protective and damaging inflammatory response].
Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre.
The pathology of multiple sclerosis.
Merck KGaA Reaches Mutual Agreement with Ono Pharmaceutical to Terminate the License Agreement on Ceralifimod (ONO-4641)

Pages